In our study, significantly increased CD68 expression was observed in ART-treated animals at weeks 12 and 16, possibly indicating the recruitment of tumor-associated macrophages, particularly of the M2 phenotype, known for their pro-tumoral role. Here, CD68 is linked to neoplasm.